A Deep Dive into Sanger Sequencing Market 2025: Key Drivers, Growth Factors, and Projections 2025-2034

"What industry-specific factors are fueling the growth of the sanger sequencing market?
The anticipated increase in genetic diseases is believed to fuel the expansion of the Sanger sequencing market in the coming times. A genetic disease refers to a health issue resulting from abnormalities or changes in a person's DNA, which is the hereditary substance containing genetic data. Sanger sequencing is a technique employed to accurately detect the sequence of nucleotides (DNA's components) in a particular gene or DNA segment to identify these diseases. As per data from the National Health Service, a public healthcare system based in the UK, an estimated 2,300 individuals in the UK were diagnosed with thalassaemia as of August 2024. Of this group, roughly 800 have a critical form of the disorder, requiring continuous blood transfusions. Therefore, the noted increase in genetic ailments is playing a significant part in escalating the growth of the Sanger sequencing market.

Get Your Sanger Sequencing Market Report Here:
https://www.thebusinessresearchcompany.com/report/sanger-sequencing-global-market-report

What Is the projected market size and growth rate for the sanger sequencing market?
The market size for Sanger sequencing has seen a rapid increase in recent years. It's projected to rise from $2.75 billion in 2024 to $3.3 billion in 2025, flaunting a compound annual growth rate (CAGR) of 19.8%. This historical period growth is largely due to a surge in research needs, growing medical diagnostics, accelerated pharmaceutical development, enhanced agricultural usage, intensified forensic evaluations, expanded biomarker discovery, and heightened genetic evolution studies.

The market size of sanger sequencing is anticipated to expand significantly in the coming years, with a projection to reach $6.17 billion in 2029, at a compound annual growth rate (CAGR) of 16.9%. This substantial growth in the forecasted period can be linked to the growing integration of clinical genomics, enhanced agricultural genomics, heightened drug safety and pharmacogenomics, the rise in prenatal and newborn screening, and the surge in environmental DNA analysis. Key trend developments in this projected period encompass advancements in technology, escalated demand for next-generation sequencing, the surge of applications in clinical diagnostics, increased funding in genomics research, and its broadening use in personalized medicine.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13925&type=smp

What new trends are reshaping the sanger sequencing market and its opportunities?
Leading corporations within the Sanger sequencing market are concentrating their efforts on enlarging genomic laboratories, with the aim of delivering speedy Sanger sequencing solutions in the North of England. These genomic labs are distinguished establishments that carry out genetic examinations and analyses to explore the makeup, role, and heredity of genes and genomes, often used in diagnostics, research, and personalized medicine applications. For example, in June 2023, Source Genomics, a firm based in the UK that provides genomic services, announced the expansion of their genomic lab into the North of the UK. This move will augment their Sanger sequencing service capabilities and expedite data delivery times. The expansion of laboratory activities to the northern regions represents a significant step towards delivering equal access to genomic services for research entities across the country. This expansion will enable customers nationwide to avail superior quality Sanger sequencing services with faster turnaround times.

What major market segments define the scope and growth of the sanger sequencing market?
The sanger sequencing market covered in this report is segmented -

1) By Sequencing: Shotgun Sequencing, Targeted Gene Sequencing, Other Sequencing
2) By Laboratory: Wet Labs, Dry Labs
3) By Research: In-House, Outsourced
4) By Application: Diagnostics, Biomarkers and Cancer, Reproductive Health, Personalized Medicine, Forensics, Other Applications
5) By End User: Academic, Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals, Clinics

Subsegments:
1) By Shotgun Sequencing: Whole Genome Shotgun Sequencing, Metagenomic Shotgun Sequencing
2) By Targeted Gene Sequencing: Amplicon Sequencing, Exome Sequencing
3) By Other Sequencing: Nested PCR Sequencing, Sequencing By Synthesis (SBS)

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13925

North America was the largest region in the sanger sequencing market in 2024. The regions covered in the sanger sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which key market leaders are driving the sanger sequencing industry growth?
Major companies operating in the sanger sequencing market report are Hoffmann-La Roche, Thermo Fisher Scientific Inc., Merck KGaA, Eurofins Scientific, Illumina Inc., Beckman Coulter, PerkinElmer Inc., BGI Group, LGC Limited, GenScript, Oxford Nanopore Technologies, Pacific Biosciences of California Inc., Macrogen Inc., GENEWIZ Inc., Quintara Biosciences, CeMIA SA, Source BioScience, Microsynth AG, Fasteris SA, GenHunter Corporation, Nucleics Pty. Ltd., SciGenom Labs Pvt. Ltd., StarSEQ GmbH, GATC Biotech AG, Agilent Technologies

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=13925&type=smp

What Is Covered In The Sanger Sequencing Global Market Report?

•Market Size Forecast: Examine the sanger sequencing market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the sanger sequencing market for a structured understanding.
•Key Players Overview: Analyze major players in the sanger sequencing market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the sanger sequencing market.
•Segment Contributions: Evaluate how different segments drive overall growth in the sanger sequencing market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the sanger sequencing market.
•Industry Challenges: Identify potential risks and obstacles affecting the sanger sequencing market.
•Competitive Landscape: Review strategic developments in the sanger sequencing market, including expansions, agreements, and new product launches.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
•LinkedIn: https://in.linkedin.com/company/the-business-research-company
•Twitter: https://twitter.com/tbrc_info
•YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.